-
Orbit Genomics Appoints Renowned Life Sciences Attorney Vern Norviel to Advisory Board
Orbit Genomics, a pioneer in redefining precision medicine, today announced the appointment of Vern Norviel, JD, MS, to its Advisory Board. A highly respected attorney and strategist in biotechnology and intellectual property law, Norviel brings decades of experience advising companies and investors at the forefront of life science innovation. “Vern’s rare ability to blend deep
-
Orbit Genomics Named Finalist in Startup Prize Focus on Health
Orbit Genomics is proud to announce that we have been named a finalist in the Startup Prize Focus on Health competition, an initiative that spotlights transformative innovation in healthcare and life sciences. This recognition highlights the impact and potential of our patented OrbiSeq™ platform, an AI-powered approach to transform diagnosis, treatment and prevention of complex
-
Orbit Genomics Appoints Strategic Communications and Capital Markets Leader Julie Silber to Board of Directors
Orbit Genomics, a pioneer in redefining precision medicine, today announced the appointment of Julie Silber to its Board of Directors. Silber brings over 25 years of experience in investor relations, capital markets, corporate strategy, and board advisory, with expertise in the diagnostics and life sciences sectors to support Orbit’s next phase of growth in precision